Neovasc Inc.(NASDAQ : NVCN)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
Loading NVCN News...
Health Technology » Medical Specialties
|BCR||C. R. Bard, Inc.||0.73%||307.82||1.6%||$420.79m|
|ISRG||Intuitive Surgical, Inc.||-0.08%||835.87||7.5%||$303.78m|
|BDX||Becton, Dickinson and Company||2.47%||187.06||1.3%||$288.66m|
|TMO||Thermo Fisher Scientific Inc.||-0.85%||165.28||1.0%||$272.30m|
|BSX||Boston Scientific Corporation||0.78%||26.39||1.1%||$204.45m|
|BAX||Baxter International Inc.||0.47%||55.68||1.7%||$202.35m|
|EW||Edwards Lifesciences Corporation||0.01%||109.68||1.2%||$201.37m|
|ZBH||Zimmer Biomet Holdings, Inc.||1.27%||119.60||1.7%||$132.37m|
|ALGN||Align Technology, Inc.||12.10%||134.62||6.2%||$109.43m|
|VAR||Varian Medical Systems, Inc.||1.97%||90.77||8.8%||$98.62m|
|IDXX||IDEXX Laboratories, Inc.||3.05%||167.73||3.7%||$95.19m|
Neovasc, Inc. operates as a medical device company that develops, manufactures, and markets products for the rapidly growing cardiovascular device marketplace. Its products include the Neovasc Reducer for the treatment of refractory angina and the Tiara technology in development for the transcatheter treatment of mitral valve disease. It operates through the following geographical segments: U.S., Europe, and the Rest of the World. The company was founded on November 2, 2000 and is headquartered in Richmond, Canada.